PEOPLE ON THE MOVE
GRAM
Grand River Aseptic Manufacturing has made Mark Kontny its newest board member.
The latest director brings thirty years of experience to GRAM, having recently served as president of pharmaceutical development services and CSO at Patheon. Kontny has also worked for Abbott Laboratories, Boehringer Ingelheim, and Pfizer, where he was a senior director overseeing small molecule and biologic development.
Tom Ross, GRAM CEO, commented “We look forward to the leadership that Mark will provide as a GRAM Board Member. His deep industry experience and knowledge of the pharmaceutical industry, specifically the parenteral space, will contribute to great decisions for the future. We have already benefitted from Mark’s counsel and we are happy to welcome him to the board.”